Chronic colonization with Pseudomonas aeruginosa (PA) in CF patients shows more rapidly decline in pulmonary function (PF). Objective: To compare the PF and clinical characteristics of CF patients according to the colonization with PA. Methods: Observational cross-sectional study. We collected data from CF patients who were performed at least four sputum cultures from September 2009 to September 2010. We divided them into four groups according to Leeds Criteria: Chronic infection, Intermittent colonization, Free and Never. We considered: age, genetics, pulmonary function, nutritional status, intravenous (IV) antibiotics and PA antibodies. Results: We evaluated 97 CF patients: 26% Chronic, 25% Intermittent, 27% Free and 19 % Never. The current age (median and interquartile range) was 10.7 (8.5 to 16.2), 5.8 (2.78 to 7.67), 5.5 (4.7 to 8.9) and 4.2 (0.97 to 5.3), respectively (p < 0.001). The homozygous p.508 del was present in 34%, 56%, 29%, and 31% of patients, respectively (p = NS). PA antibodies was 7.6 (4.5 to 16.5), 1.6 (1 to 1.8), 1.5 (1to 2.6) and 0.8 (0.6 to 1), respectively (p < 0.001). The Zscore BMI was −0.39 (−1.14 to 0.13), −0.1 (−0.81 to 0.31), 0.19 (−0.28 to 0.83) and 0.11 (−0.94 to 0.37) in each group (p = NS). The FEV 1 was 63 (47.5 to 92.2), 79 (54.7 to 108), 99 (85 to 105) and 109 (105.7 to 112), respectively (p = 0.06). (Chronic vs. Free p = 0.007 and Chronic vs. Never p < 0.001). Iv Antibiotic treatments were required in 1 (0−1), 1 (1−2), 0 (0−1) and 0 (0−0), respectively (p < 0.01). Conclusion: Chronic infection with PA determined lower pulmonary function, more iv antibiotics treatments and had higher level of antibodies than the others groups.
Little is known about the dynamics of TA CT over time.
Aims: To assess the course and reversibility of TA CT over 2 years. Methods: TA was assessed on 2 consecutive routine expiratory CT scans (TA CT1 , TA CT2 ). Lung tissue was segmented to determine Total Lung Volume (TLV). TA volume was determined using thresholds between −975 HU and −700 HU (manually determined). TA CT was expressed in percentage TLV. To assess TA CT reversibility, CT 2 and its corresponding TA masks were non-rigidly deformed to match CT 1 .
The volume of TA that was unchanged, disappeared or new relative to CT 1 was measured and expressed in percentage overlap volume. Statistical analysis included Wilcoxon's signed rank test. Results: 26 patients (14 boys) were included. Baseline median (range) age and FEV 1 were 11.9 (5−17) years, and 91 (39-130) %-predicted. Median (range) TA CT1 and TA CT2 were respectively 9.5% (2−33%) and 8.0% (0−26%) (p = 0.56). Median (range) TA CT volume unchanged, disappeared, and new in CT 2 relative to CT 1 was respectively 3.0% (0−12%), 5.3% (1−22%) and 6.6% (0−20%). The proportion new and reversed TA was significantly higher than the proportion stable TA (p = 0.001 and p = 0.003).
Conclusions:
In this study, TA CT was not progressive over 2 years, and overall, TA appeared to be more dynamic than static over time.
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